Northeast Financial Consultants’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1K | Buy |
+10,000
| New | +$12.1K | ﹤0.01% | 299 |
|
|
2024
Q4 | – | Sell |
-10,000
| Closed | -$32.9K | – | 297 |
|
|
2024
Q3 | $32.9K | Hold |
10,000
| – | – | ﹤0.01% | 289 |
|
|
2024
Q2 | $42.5K | Hold |
10,000
| – | – | ﹤0.01% | 268 |
|
|
2024
Q1 | $147K | Hold |
10,000
| – | – | 0.01% | 279 |
|
|
2023
Q4 | $96.2K | Hold |
10,000
| – | – | 0.01% | 274 |
|
|
2023
Q3 | $46.6K | Hold |
10,000
| – | – | ﹤0.01% | 281 |
|
|
2023
Q2 | $53.5K | Hold |
10,000
| – | – | ﹤0.01% | 283 |
|
|
2023
Q1 | $71.7K | Hold |
10,000
| – | – | ﹤0.01% | 309 |
|
|
2022
Q4 | $67.1K | Hold |
10,000
| – | – | ﹤0.01% | 315 |
|
|
2022
Q3 | $35K | Hold |
10,000
| – | – | ﹤0.01% | 331 |
|
|
2022
Q2 | $30K | Hold |
10,000
| – | – | ﹤0.01% | 328 |
|
|
2022
Q1 | $88K | Hold |
10,000
| – | – | 0.01% | 381 |
|
|
2021
Q4 | $161K | Hold |
10,000
| – | – | 0.01% | 339 |
|
|
2021
Q3 | $209K | Hold |
10,000
| – | – | 0.01% | 329 |
|
|
2021
Q2 | $269K | Hold |
10,000
| – | – | 0.02% | 298 |
|
|
2021
Q1 | $319K | Hold |
10,000
| – | – | 0.02% | 264 |
|
|
2020
Q4 | $229K | Hold |
10,000
| – | – | 0.02% | 292 |
|
|
2020
Q3 | $252K | Hold |
10,000
| – | – | 0.02% | 251 |
|
|
2020
Q2 | $279K | Hold |
10,000
| – | – | 0.03% | 225 |
|
|
2020
Q1 | $58K | Hold |
10,000
| – | – | 0.01% | 262 |
|
|
2019
Q4 | $109K | Hold |
10,000
| – | – | 0.01% | 300 |
|
|
2019
Q3 | $128K | Hold |
10,000
| – | – | 0.01% | 313 |
|
|
2019
Q2 | $170K | Hold |
10,000
| – | – | 0.02% | 317 |
|
|
2019
Q1 | $180K | Hold |
10,000
| – | – | 0.02% | 306 |
|
|
2018
Q4 | $127K | Buy |
+10,000
| New | +$127K | 0.02% | 151 |
|